🇺🇸 FDA
Pipeline program

Hard capsules, BIIB141

296FA301

Phase 3 small_molecule active

Quick answer

Hard capsules, BIIB141 for Friedreich’s ataxia is a Phase 3 program (small_molecule) at Biogen Idec Ltd with 1 ClinicalTrials.gov record(s).

Program details

Company
Biogen Idec Ltd
Indication
Friedreich’s ataxia
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials